Abstract:Stochastic curtailment is a valuable tool in monitoring long-term medical studies. Under this approach, one calculates the conditional power, which is the probability of rejecting the null hypothesis at the scheduled end of the study given the existing data at the interim analysis, along with certain speculation about the future data. The conditional power may be used to aid the decision to terminate a study prematurely or to extend a study beyond its originally planned duration. This article provides a formal and systematic investigation into the use of stochastic curtailment in the context of censored survival data. To enhance generality, we introduce a broad class of statistics that includes two-sample weighted log-rank statistics, as well as the partial likelihood score statistic for testing treatment difference with covariate adjustment under the proportional hazards model. We establish the weak convergence under both the null hypothesis and contiguous alternatives for this class of statistics when calculated repeatedly over the calendar time (i.e., time of interim analysis). Further, we derive the conditional distributions of these statistics calculated at the end of the study given all the data collected up to the interim look or given the statistics calculated at the interim look, and provide analytic expressions for the corresponding conditional powers. These results enable us to address several subtle issues involved in the definition and implementation of conditional power for censored survival data, especially when there is staggered patient entry with a potential time trend in the survival distribution, when the Gehan-type weight function is used, or when treatment is not independent of covariates. For randomized clinical trials, we show that very simple formulas can be used to calculate the conditional powers of the unweighted log-rank test (with or without covariate adjustment) under both the null and alternative hypotheses. Simulation studies demonstrate that the conditional powers for survival studies can be accurately evaluated through the proposed formulas even when the sample size is small. An illustration with data taken from a colon cancer study is provided.

A NOTE ON POWER CALCULATION FOR GENERALIZED CASE-COHORT SAMPLING WITH ACCELERATED FAILURE TIME MODEL

Accelerated failure time model for data from outcome-dependent sampling

Accelerated Failure Time Model under General Biased Sampling Scheme.

Fast Accelerated Failure Time Modeling for Case-Cohort Data

CASE-CONTROL SURVIVAL ANALYSIS WITH A GENERAL SEMIPARAMETRIC SHARED FRAILTY MODEL - A PSEUDO FULL LIKELIHOOD APPROACH

Regression Analysis of the Generalized Accelerated Hazards Models With Interval‐Censored Data Under Case‐Cohort Studies

Efficient Estimation for Functional Accelerated Failure Time Model

Improving estimation efficiency of case-cohort study with interval-censored failure time data

Polynomial-Based Smoothing Estimation for a Semiparametric Accelerated Failure Time Partial Linear Model

Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model

Generalized Estimating Equations for Survival Data With Dependent Censoring

Generalized Residual-Based Diagnostic Testing for Duration Models with Censoring

Non- and semi-parametric analysis of failure time data with missing failure indicators

Semiparametric Bayesian Inference for Accelerated Failure Time Models with Errors-in-covariates and Doubly Censored Data

A fast algorithm for the accelerated failure time model with high-dimensional time-to-event data

Marginal Hazards Model for Multivariate Failure Time Data with Auxiliary Covariates

FUSED KERNEL-SPLINE SMOOTHING FOR REPEATEDLY MEASURED OUTCOMES IN A GENERALIZED PARTIALLY LINEAR MODEL WITH FUNCTIONAL SINGLE INDEX

A General Theory on Stochastic Curtailment for Censored Survival Data

Accelerated failure time models with error-prone response and nonlinear covariates

Optimal subsampling for parametric accelerated failure time models with massive survival data

Rank-Based Inference for the Accelerated Failure Time Model